Literature DB >> 10943408

Molecular mechanisms of malaria sporozoite motility and invasion of host cells.

A A Sultan1.   

Abstract

Malaria sporozoites have the unique capacity to invade two entirely different types of target cell in the mosquito vector and the vertebrate host during the course of the parasite's life cycle. Although little is known about the specific interaction of the sporozoite with its target cells, two sporozoite proteins, circumsporozoite (CS) and thrombospondin-related adhesive protein (TRAP), have been shown to play important roles in the invasion of both cell types. CS protein is a multifunctional protein involved in sporogony, invasion of the salivary glands, the specific arrest of sporozoites in the liver sinusoid, gliding motility of the sporozoite, and hepatocyte recognition and entry. TRAP has been shown to be critical for sporozoite infection of the mosquito salivary glands and liver cells, and is essential for sporozoite gliding motility. This review will focus on the involvement of these molecules in sporozoite motility and the invasion of host cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10943408

Source DB:  PubMed          Journal:  Int Microbiol        ISSN: 1139-6709            Impact factor:   2.479


  8 in total

Review 1.  Developmental biology of sporozoite-host interactions in Plasmodium falciparum malaria: implications for vaccine design.

Authors:  Javier E Garcia; Alvaro Puentes; Manuel E Patarroyo
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

2.  Cryptosporidium parvum genes containing thrombospondin type 1 domains.

Authors:  Mingqi Deng; Thomas J Templeton; Nicole R London; Carrey Bauer; Alison A Schroeder; Mitchell S Abrahamsen
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

Review 3.  Host-Parasite Interactions in Human Malaria: Clinical Implications of Basic Research.

Authors:  Pragyan Acharya; Manika Garg; Praveen Kumar; Akshay Munjal; K D Raja
Journal:  Front Microbiol       Date:  2017-05-18       Impact factor: 5.640

4.  Plasmodium malariae Prevalence and csp Gene Diversity, Kenya, 2014 and 2015.

Authors:  Eugenia Lo; Kristie Nguyen; Jennifer Nguyen; Elizabeth Hemming-Schroeder; Jiaobao Xu; Harrisone Etemesi; Andrew Githeko; Guiyun Yan
Journal:  Emerg Infect Dis       Date:  2017-04       Impact factor: 6.883

5.  Prediction of Human-Plasmodium vivax Protein Associations From Heterogeneous Network Structures Based on Machine-Learning Approach.

Authors:  Apichat Suratanee; Teerapong Buaboocha; Kitiporn Plaimas
Journal:  Bioinform Biol Insights       Date:  2021-06-16

6.  Cell-passage activity is required for the malarial parasite to cross the liver sinusoidal cell layer.

Authors:  Tomoko Ishino; Kazuhiko Yano; Yasuo Chinzei; Masao Yuda
Journal:  PLoS Biol       Date:  2004-01-20       Impact factor: 8.029

7.  A phase 1b randomized, controlled, double-blinded dosage-escalation trial to evaluate the safety, reactogenicity and immunogenicity of an adenovirus type 35 based circumsporozoite malaria vaccine in Burkinabe healthy adults 18 to 45 years of age.

Authors:  Alphonse Ouédraogo; Alfred B Tiono; Désiré Kargougou; Jean Baptiste Yaro; Esperance Ouédraogo; Youssouf Kaboré; David Kangoye; Edith C Bougouma; Adama Gansane; Noelie Henri; Amidou Diarra; Souleymane Sanon; Issiaka Soulama; Amadou T Konate; Nora L Watson; Valerie Brown; Jenny Hendriks; Maria Grazia Pau; Isabella Versteege; Edison Wiesken; Jerald Sadoff; Issa Nebie; Sodiomon B Sirima
Journal:  PLoS One       Date:  2013-11-11       Impact factor: 3.240

8.  Differing patterns of selection and geospatial genetic diversity within two leading Plasmodium vivax candidate vaccine antigens.

Authors:  Christian M Parobek; Jeffrey A Bailey; Nicholas J Hathaway; Duong Socheat; William O Rogers; Jonathan J Juliano
Journal:  PLoS Negl Trop Dis       Date:  2014-04-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.